American Century Companies Inc. decreased its stake in shares of Welltower Inc. (NYSE:WELL - Free Report) by 4.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,123,762 shares of the real estate investment trust's stock after selling 46,227 shares during the period. American Century Companies Inc. owned 0.17% of Welltower worth $172,172,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the business. Capital International Investors grew its stake in shares of Welltower by 0.9% in the fourth quarter. Capital International Investors now owns 37,096,408 shares of the real estate investment trust's stock valued at $4,674,826,000 after buying an additional 318,496 shares in the last quarter. Bank of America Corp DE lifted its stake in Welltower by 9.7% during the fourth quarter. Bank of America Corp DE now owns 18,706,788 shares of the real estate investment trust's stock worth $2,357,617,000 after purchasing an additional 1,652,611 shares during the last quarter. Northern Trust Corp raised its stake in Welltower by 53.5% during the fourth quarter. Northern Trust Corp now owns 8,430,496 shares of the real estate investment trust's stock worth $1,062,495,000 after acquiring an additional 2,939,229 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Welltower by 10.3% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,632,705 shares of the real estate investment trust's stock valued at $961,950,000 after purchasing an additional 712,279 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Welltower by 14.4% during the first quarter. Charles Schwab Investment Management Inc. now owns 6,956,594 shares of the real estate investment trust's stock valued at $1,065,820,000 after acquiring an additional 877,856 shares during the period. 94.80% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Welltower news, Director Andrew Gundlach bought 20,000 shares of the business's stock in a transaction that occurred on Monday, June 30th. The shares were acquired at an average cost of $151.46 per share, for a total transaction of $3,029,200.00. Following the transaction, the director directly owned 20,000 shares in the company, valued at approximately $3,029,200. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.21% of the stock is currently owned by insiders.
Welltower Trading Up 0.6%
Shares of WELL traded up $1.0190 during trading hours on Tuesday, hitting $163.4290. 1,691,806 shares of the stock traded hands, compared to its average volume of 2,946,563. The firm has a market capitalization of $109.31 billion, a PE ratio of 92.33, a price-to-earnings-growth ratio of 1.87 and a beta of 0.93. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.44. Welltower Inc. has a 1-year low of $115.49 and a 1-year high of $171.09. The business has a fifty day moving average of $158.13 and a 200-day moving average of $151.80.
Welltower (NYSE:WELL - Get Free Report) last posted its earnings results on Monday, July 28th. The real estate investment trust reported $1.28 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.22 by $0.06. The firm had revenue of $2.55 billion during the quarter, compared to analysts' expectations of $2.49 billion. Welltower had a return on equity of 3.38% and a net margin of 12.18%.The company's revenue was up 39.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.05 earnings per share. Welltower has set its FY 2025 guidance at 5.060-5.14 EPS. Analysts expect that Welltower Inc. will post 4.88 EPS for the current year.
Welltower Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 21st. Investors of record on Tuesday, August 12th will be paid a $0.74 dividend. This represents a $2.96 annualized dividend and a yield of 1.8%. This is a boost from Welltower's previous quarterly dividend of $0.67. The ex-dividend date of this dividend is Tuesday, August 12th. Welltower's payout ratio is 167.23%.
Analysts Set New Price Targets
A number of research firms have weighed in on WELL. Scotiabank restated an "outperform" rating on shares of Welltower in a research report on Monday, June 23rd. Morgan Stanley increased their price objective on Welltower from $155.00 to $160.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 6th. Wells Fargo & Company increased their price objective on Welltower from $158.00 to $175.00 and gave the stock an "overweight" rating in a report on Monday, June 2nd. Wall Street Zen lowered shares of Welltower from a "hold" rating to a "sell" rating in a research note on Thursday, May 8th. Finally, Evercore ISI upped their target price on Welltower from $162.00 to $175.00 and gave the stock an "in-line" rating in a research report on Wednesday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $169.82.
Check Out Our Latest Analysis on WELL
About Welltower
(
Free Report)
Welltower Inc NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.
See Also

Before you consider Welltower, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Welltower wasn't on the list.
While Welltower currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report